Section Arrow
LEGN.NASDAQ
- Legend Biotech Corp
Quotes are at least 15-min delayed:2026/02/24 04:21 EST
Pre Market
Last
 19.71
-0.04 (-0.20%)
Bid
19.46
Ask
20
High 19.98 
Low 19.58 
Volume 1.98K 
Regular Hours (Closed)
Last
 19.75
+1.63 (+9.00%)
Day High 
21.58 
Prev. Close
18.12 
1-M High
22.04 
Volume 
780 
Bid
19.46
Ask
20
Day Low
18.94 
Open
21.07 
1-M Low
16.24 
Market Cap 
3.35B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 17.93 
20-SMA 17.79 
50-SMA 20.45 
52-W High 45.2972 
52-W Low 16.24 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.28/1.95
Enterprise Value
3.69B
Balance Sheet
Book Value Per Share
5.48
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
627.24M
Operating Revenue Per Share
0.89
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ELABPMGC Holdings Inc.1.21-0.08-6.20%0.01PE
Pre Market 1.21 0 0.00%
LIMNLiminatus Pharma Inc0.2354+0.0064+2.79%-- 
Pre Market 0.2305 -0.0049 -2.08%
CAICaris Life Sciences Inc17.63-1.9-9.73%-- 
Pre Market 17.8 +0.17 +0.96%
RPRXRoyalty Pharma plc45.47+0.35+0.78%25.35PE
Pre Market -- -- --
MENSJyong Biotech Ltd2.73+0.72+35.82%-- 
Pre Market 2.7 -0.03 -1.10%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.